Covaxin
-
Health News
National Regulator approves “Conditional Market Authorization” of two COVID19 Vaccines- Covaxin and Covishield
The National Regulator, Drugs Controller General of India (DCGI), has given nod to market authorization of two COVID19 vaccines, Covaxin…
Read More » -
Health News
Union Minister for Health and Family Welfare and Chemicals and Fertilizers, Shri Mansukh Mandaviya releases first commercial batch of COVAXIN manufactured in Ankleshwar, Gujarat
Shri. Mansukh Mandaviya today released the first commercial batch of COVAXIN from the Chiron Behring Vaccines facility of Bharat Biotech…
Read More » -
PIB Press Releases
DCGI approves Phase II/III clinical trial of COVAXIN in the age group of 2 to 18 Years
The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation…
Read More » -
India News
Bharat Biotech announces Covaxin price; Rs 600 for states, Rs 1200 for private hospitals
Covaxin, the indigenous vaccine against COVID-19 will be available for state governments at Rs 600 per dose and private hospitals…
Read More »